Solutions

Resources

Company

Solutions

Resources

Company

Trially Connect: Margo AI Gives Clinical Research Coordinators the Backup They Deserve

Published:

Portrait of Trially AI agent Margo in white coat against a pink background
Portrait of Trially AI agent Margo in white coat against a pink background

Introduction

Let us talk about the elephant in the room: the clinical trial industry is facing a severe staffing and efficiency crisis. Globally, we are staring down a projected shortfall of ten million healthcare workers by the year 2030, and the staff we currently have are experiencing rampant burnout driven by crushing administrative overload. For sponsors, CROs, and research sites, the central bottleneck to clinical development is no longer simply whether enough potential participants exist in the world. The real problem is whether trials can be managed so the right patients are identified and enrolled without entirely overwhelming the research sites.

Current data shows that approximately 80 percent of clinical studies are unable to hit their baseline recruitment targets on time, which ultimately results in severe financial setbacks as the project drags on. Clinical research sites are bearing the brunt of this, typically spending upwards of 250 hours every single month just doing manual screening.

Enter Trially Connect and its core conversion engine, Margo AI. Instead of throwing more overworked human coordinators at a fundamentally broken system, Connect and Margo step in as the ultimate solution. Margo is an intelligent conversational agent that handles the heavy lifting of the patient conversion funnel, completely transforming clinical research workflows to solve this staffing crisis.

Administrative Gaps

To fully grasp why a solution like Margo is so critical, we have to look at the daily administrative weaknesses that quietly slow down trial operations and inflate study costs. Even when a study has strong protocols and qualified investigators, administrative bottlenecks consistently get in the way of scientific progress. Many enrollment setbacks actually originate from administrative inefficiencies within screening workflows, such as delayed eligibility verification, incomplete pre-screening logs, and poor integration between electronic medical records and recruitment tools.

Research sites often rely on multiple independent systems that do not interact with one another, resulting in technology silos that force staff into manual data re-entry and inconsistent documentation. When site coordinators are forced to manually review endless charts and manage fragmented email chains just to figure out who owns a task, their administrative workload balloons to an unmanageable size.

This is exactly the tedious background work that Margo automates. Margo is engineered to eliminate the manual and time-intensive patient-physician handoff. It automates the crucial follow-up steps that humans simply do not have the time for, including pre-screening patients, scheduling appointments, and sending consistent reminders through text messages and voice calls. By doing this, Trially achieves a staggering 90 percent reduction in the manual chart review hours required of clinical research coordinators every month.

Practical AI vs. Theory

For a long time, the conversation around artificial intelligence in clinical research has been stuck in the clouds. Old, high-level theories focused broadly on predictive models and cohort selection opportunities, but they often failed to address the boots-on-the-ground reality of site burden, intense HIPAA regulations, and the strict need for human oversight. Industry leaders have rightly warned against buying AI as a standalone technology fix that just adds another login, another workflow, and another burden to already stretched study teams.

Trially stands apart by turning theoretical potential into a practical, integrated reality. The success of large language models in healthcare hinges on robust foundations in compliance and governance, and Trially handles this data security beautifully. The platform operates within a highly secure framework that is fully compliant with HIPAA, SOC 2, FDA 21 CFR Part 11, and ISO 27001 regulations. It protects sensitive data using AES-256 encryption at rest and TLS encryption in transit.

Furthermore, Trially was built by world-class Zapier AI engineers to keep site workflows intact, meaning it plugs directly into the electronic health records and clinical trial management systems sites already use. Most importantly, Margo operates as an IRB-approved clinical research agent. It acts as a decision-support tool rather than an autonomous decision-maker. By generating real-time patient qualification summaries, Margo ensures transparent documentation so that the clinical staff quickly understands why a patient qualifies, ensuring the physician always retains the final decision-making authority.

Patient Matching Engine

Finding the right patients is notoriously difficult because a massive amount of eligibility data is completely hidden. While health systems hold structured data like diagnosis codes, the true clinical context usually sits locked away in unstructured physician notes, pathology reports, and complex genomic PDFs.

Trially Match, the intelligence feeding Margo AI, safely and comprehensively reads 100 percent of both structured and unstructured electronic health record data in real time. By synthesizing this deep information using natural-language processing, the platform instantly matches patients against complex trial protocols with an incredible 95 percent accuracy. This is particularly vital in complex therapeutic areas like oncology, where critical patient context resides almost entirely in unstructured notes. By automating this deep analysis, Trially increases monthly enrollment for complex studies by two to six times and drastically reduces screen failure rates by 73%.

Ultimately, the greatest return on investment provided by Trially is human. Clinical research coordinators are often the hidden constraints in trial execution because they are buried in paperwork. By taking over the tedious data synthesis and outreach, Margo drastically reduces coordinator burnout, allowing staff to spend less time battling paperwork and more time practicing medicine. The efficiency gains are so profound that a single coordinator supported by Trially can achieve the exact same enrollment rate as a top academic medical center utilizing a team of twenty manual coordinators. By reducing burnout and automating the background noise, Trially finally empowers clinical research sites to scale their operations efficiently and humanely.



Last Updated:

Get the latest from Trially AI delivered to your inbox.

Get the latest from Trially AI delivered to your inbox.

Get the latest from Trially AI delivered to your inbox.

©

All rights reserved.

All information presented is for illustrative purposes only and does not represent actual data. Trially's product is fully compliant with HIPAA, SOC 2, FDA 21 CFR Part 11 and ISO 27001 regulations, ensuring the highest level of data security, safety and privacy.

©

All rights reserved.

All information presented is for illustrative purposes only and does not represent actual data. Trially's product is fully compliant with HIPAA, SOC 2, FDA 21 CFR Part 11 and ISO 27001 regulations, ensuring the highest level of data security, safety and privacy.

©

All rights reserved.

All information presented is for illustrative purposes only and does not represent actual data. Trially's product is fully compliant with HIPAA, SOC 2, FDA 21 CFR Part 11 and ISO 27001 regulations, ensuring the highest level of data security, safety and privacy.